Literature DB >> 7069577

Pharmacokinetics of cefroxadin (CGP 9000) in man.

A Gerardin, J B Lecaillon, J P Schoeller, G Humbert, J Guibert.   

Abstract

The pharmacokinetics of cefroxadin have been studied after the administration of single oral and intravenous doses to healthy volunteers. Cefroxadin was assayed by HPLC. The kinetics in plasma following i.v. administration were described by using a three-compartment model. An additional disposition phase was observed following oral administration that could not be detected after the low i.v. dose. The terminal half-life was 1.03 h. The apparent volume of distribution at the steady state was consistent with a diffusion of the antibiotic in all extracellular fluids. The AUC after oral administration was linearly related to the dose. The urinary excretion amounted to 95% of the dose with virtually complete absorption of orally administered drug.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7069577     DOI: 10.1007/bf01059181

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  9 in total

Review 1.  Pharmacokinetics and clinical use of cephalosporin antibiotics.

Authors:  C H Nightingale; D S Greene; R Quintiliani
Journal:  J Pharm Sci       Date:  1975-12       Impact factor: 3.534

2.  CGP 9000: a new orally active, broad-spectrum cephalosporin.

Authors:  O Zak; W A Vischer; C Schenk; W Tosch; W Zimmermann; J Regös; E R Suter; F Kradolfer; J Gelzer
Journal:  J Antibiot (Tokyo)       Date:  1976-06       Impact factor: 2.649

3.  Penetration of four cephalosporins into tissue fluid in man.

Authors:  A P Gillett
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

4.  Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans.

Authors:  J B Lecaillon; J L Hirtz; J P Schoeller; G Humbert; W Vischer
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

5.  [Pharmacokinetic comparative studies on the resorption of 3 new cephalosporins].

Authors:  H Lode; R Stahlmann; G Dzwillo; P Koeppe
Journal:  Verh Dtsch Ges Inn Med       Date:  1978

6.  Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

Authors:  H Lode; R Stahlmann; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

7.  Physiological perfusion model for cephalosporin antibiotics I: Model selection based on blood drug concentrations.

Authors:  D S Greene; R Quintiliani; C H Nightingale
Journal:  J Pharm Sci       Date:  1978-02       Impact factor: 3.534

8.  In vitro activity against Escherichia coli of CGP 9000, a new oral cephalosporin.

Authors:  D Greenwood
Journal:  J Antibiot (Tokyo)       Date:  1978-07       Impact factor: 2.649

9.  Pharmacokinetics of a new cephalosporin, CGP 9000 (cefroxadine), in healthy volunteers.

Authors:  T Bergan
Journal:  Chemotherapy       Date:  1980       Impact factor: 2.544

  9 in total
  6 in total

Review 1.  Interethnic differences in pharmacokinetics of antibacterials.

Authors:  Danny Tsai; Janattul-Ain Jamal; Joshua S Davis; Jeffrey Lipman; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

2.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

3.  An incremental method for the study of the absorption of drugs whose kinetics are described by a two-compartment model: estimation of the microscopic rate constants.

Authors:  A Gerardin; D Wantiez; A Jaouen
Journal:  J Pharmacokinet Biopharm       Date:  1983-08

4.  Negative power functions of time in pharmacokinetics and their implications.

Authors:  M E Wise
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

5.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics.

Authors:  W R Gillespie; P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1985-08

6.  Absorption kinetics and model characteristics of orally administered pirprofen.

Authors:  A Gerardin; R C Luders; W E Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1983-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.